Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ho

Showing results (231-240 of 549) with videos related to

Pageof 55
Sort By:
JAMA Internal Medicine|December 12, 2012
Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new usersAlyce S Adams, Connie Uratsu, Wendy Dyer, et al.
Circulation. Cardiovascular Interventions|June 16, 2016
Postdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction: Insights From the HMO Research Network-Stent RegistryJavier A Valle, Susan Shetterly, Thomas M Maddox, et al.
Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal OutcomesJavier A Valle, Thomas J Glorioso, Thomas M Maddox, et al.
World Neurosurgery|April 6, 2026
Effect of Anti-Siphon Devices on Postoperative Outcomes in Idiopathic Normal Pressure HydrocephalusYashaar Hafizka, Sheel Shah, Jorge Salcedo-Sifuentes, et al.
Circulation. Cardiovascular Quality and Outcomes|August 19, 2010
Comparative effectiveness of angiotensin-converting enzyme inhibitors versus beta-blockers as second-line therapy for hypertensionDavid J Magid, Susan M Shetterly, Karen L Margolis, et al.
Journal of the American Heart Association|October 22, 2017
The Impact of De-escalation of Antianginal Medications on Health Status After Percutaneous Coronary InterventionMohammed Qintar, Arooge Towheed, Fengming Tang, et al.
Infection Control and Hospital Epidemiology|June 21, 2016
Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?Westyn Branch-Elliman, Maggie Stanislawski, Judith Strymish, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 20, 2021
Racial Differences in the Use of Endoscopy and Transjugular Intrahepatic Portosystemic Shunt Creation for Treatment of Acute Variceal Bleeding in the United StatesSriram S Rao, Alexandria M Jensen, Michael S Kriss, et al.
BMJ Open|November 7, 2022
Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities studyKamal Henderson, Brystana Kaufman, Jason S Rotter, et al.
Journal of Vascular Surgery|February 22, 2011
Assessment of functional status and quality of life in claudicationRyan J Mays, Ivan P Casserly, Wendy M Kohrt, et al.
Pageof 55

Showing results (231-240 of 549) with videos related to

Sort By:
Pageof 55
JAMA Internal Medicine|December 12, 2012
Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new usersAlyce S Adams, Connie Uratsu, Wendy Dyer, et al.
Circulation. Cardiovascular Interventions|June 16, 2016
Postdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction: Insights From the HMO Research Network-Stent RegistryJavier A Valle, Susan Shetterly, Thomas M Maddox, et al.
Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal OutcomesJavier A Valle, Thomas J Glorioso, Thomas M Maddox, et al.
World Neurosurgery|April 6, 2026
Effect of Anti-Siphon Devices on Postoperative Outcomes in Idiopathic Normal Pressure HydrocephalusYashaar Hafizka, Sheel Shah, Jorge Salcedo-Sifuentes, et al.
Circulation. Cardiovascular Quality and Outcomes|August 19, 2010
Comparative effectiveness of angiotensin-converting enzyme inhibitors versus beta-blockers as second-line therapy for hypertensionDavid J Magid, Susan M Shetterly, Karen L Margolis, et al.
Journal of the American Heart Association|October 22, 2017
The Impact of De-escalation of Antianginal Medications on Health Status After Percutaneous Coronary InterventionMohammed Qintar, Arooge Towheed, Fengming Tang, et al.
Infection Control and Hospital Epidemiology|June 21, 2016
Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?Westyn Branch-Elliman, Maggie Stanislawski, Judith Strymish, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 20, 2021
Racial Differences in the Use of Endoscopy and Transjugular Intrahepatic Portosystemic Shunt Creation for Treatment of Acute Variceal Bleeding in the United StatesSriram S Rao, Alexandria M Jensen, Michael S Kriss, et al.
BMJ Open|November 7, 2022
Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities studyKamal Henderson, Brystana Kaufman, Jason S Rotter, et al.
Journal of Vascular Surgery|February 22, 2011
Assessment of functional status and quality of life in claudicationRyan J Mays, Ivan P Casserly, Wendy M Kohrt, et al.
Pageof 55